4.4 Review

Lactated Ringer's vs normal saline for acute pancreatitis: An updated systematic review and meta-analysis

Journal

PANCREATOLOGY
Volume 21, Issue 7, Pages 1217-1223

Publisher

ELSEVIER
DOI: 10.1016/j.pan.2021.06.002

Keywords

Lactated Ringer's; Normal saline; Acute pancreatitis; Mortality; ICU admission; Inflammation

Ask authors/readers for more resources

The study found that in patients with acute pancreatitis, lactated Ringer's solution improved outcomes such as ICU admission and length of stay compared to normal saline. However, there was no significant difference between the two treatments in terms of SIRS development rate and mortality.
Introduction: Recent studies have evaluated and compared the efficacy of normal saline (NS) and lactated Ringer's (LR) in reducing the severity of acute pancreatitis (AP) and improving outcomes such as length of stay, the occurrence of the systemic inflammatory response syndrome (SIRS), ICU admission and mor-tality. We performed an updated systematic review and meta-analysis of the available studies to assess the impact of these fluids on outcomes secondary to AP. Methods: We systematically searched the following databases: PubMed/Medline, Embase, Cochrane, and Web of Science through February 8th, 2021 to include randomized controlled trials (RCTs) and cohort studies. Random effects model using DerSimonian-Laird approach was employed and risk ratios (RR) and mean difference (MD) with 95% confidence interval (CI) were calculated for binary and continuous outcomes, respectively. Results: 6 studies (4 RCTs and 2 cohort studies) with 549 (230 in LR and 319 in NS) were included. The overall mortality (RR: 0.73, CI: 0.31-1.69) and SIRS at 24 h (RR: 0.69, CI: 0.32-1.51) was not significantly different. The overall ICU admission was lower in LR group compared to NS group (RR: 0.43, CI: 0.22-0.84). Subgroup analysis of RCTs demonstrated lower length of hospital stay for LR group compared to NS group (MD: 0.77 days, CI: 1.44-0.09 days). Conclusion: Our study demonstrated that LR improved outcomes (ICU admission and length of stay) in patients with AP compared to NS. There was no difference in rate of SIRS development and mortality between LR and NS treatments. (c) 2021 Published by Elsevier B.V. on behalf of IAP and EPC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available